In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-19 of 19 for your search:
Drug:  degarelix
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS21, NCT00295750
2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS21A, NCT00451958
3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS29, EudraCT No: 2008-003931-19, NCT00801242
4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS30, 2008-005232-33, NCT00833248
5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS31, 2008-008604-40, NCT00884273
6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS37, RISPSA, NCT00928434
7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS35, NCT00946920
8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS34, EudraCT No: 2008-006827-29, NCT00967018
9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS42, NCT01071915
10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS42A, NCT01215513
11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS43, NCT01220869
12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS15, NCT00116753
13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS18, NCT00468286
14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 55 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS25, 2007-003578-24, NCT00527488
15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3550-CL-0003, NCT00568516
16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS27, NCT00738673
17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3550-CL-0009, NCT01261572
18.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: FE200486 CS46, NCT01215526
19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 120
Sponsor: Other
Protocol IDs: UVA002, NCT01344564
New Search